The epidemiology of neuromuscular disorders: Age at onset and gender in the Netherlands

Neuromuscular Disorders

Volumn 26, Issue 7, 2016, Pages 447-452

  Deenen, Johanna C W ^a   van Doorn, Pieter A ^b   Faber, Catharina G ^c   van der Kooi, Anneke J ^d   Kuks, Jan B M ^e   Notermans, Nicolette C ^f   Visser, Leo H ^g   Horlings, Corinne G C ^a   Verschuuren, Jan J G M ^h   Verbeek, André L M ^a   van Engelen, Baziel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g CPRLab   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age; Epidemiology; Gender; Neuromuscular diseases; Neuromuscular disorders

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; EMERY DREIFUSS MUSCULAR DYSTROPHY; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEUROMUSCULAR DISEASE; ONSET AGE; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; SEX RATIO; ADOLESCENT; ADULT; AGED; CHILD; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEX FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NETHERLANDS; NEUROMUSCULAR DISEASES; SEX FACTORS; YOUNG ADULT;

EID: 84975497330     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2016.04.011     Document Type: Article

References (8)

1. [1] Emery, A.E.H., Diagnostic criteria for neuromuscular disorders. 1997, Royal Society of Medicine Press, London.
2. [2] Wijmenga, C., Hewitt, J.E., Sandkuijl, L.A., et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2 (1992), 26–30.
3. [3] van Deutekom, J.C., Bremmer-Bout, M., Janson, A.A., et al. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet 10 (2001), 1547–1554.
4. [4] van Engelen, B.G., van Veenendaal, H., van Doorn, P.A., et al. The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): development and preliminary data. Neuromuscul Disord 17 (2007), 33–37.
5. [5] Rowland, L.P., McLeod, J.G., Classification of neuromuscular disorders. J Neurol Sci 124:Suppl. (1994), 109–130.
6. [6] ISNO, Dutch Neuromuscular Research Centre. http://www.ISNO.nl, 1999 accessed 25.04.2016.
7. [7] Deenen, J.C., Horlings, C.G., Verschuuren, J.J., Verbeek, A.L., Van Engelen, B.G., The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis 2 (2015), 73–85.
8. [8] Tan, S.S., van Ineveld, B.M., Redekop, W.K., Hakkaart-van Roijen, L., The diagnose behandeling combinaties (DBCs). Busse, R., Geissler, A., Quentin, W., Wiley, M., (eds.) Diagnosis-related groups in Europe: moving towards transparency, efficiency and quality in hospitals, 2011, Open University Press and WHO Regional Office for Europe, Buckingham.